Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ultrastruct Pathol ; 48(1): 29-41, 2024 Jan 02.
Artigo em Inglês | MEDLINE | ID: mdl-37970647

RESUMO

Investigation the protective effect of transient receptor potential channel modulator 2-Aminoethoxydiphenyl Borate (2-APB) on aminoglycoside nephrotoxicity caused by reactive oxygen species, calcium-induced apoptosis and inflammation was aimed. Forty Wistar rats were divided (n=8) as follows: Control group; DMSO group; 2-APB group; Gentamicin group (injected 100 mg/kg gentamicin intramuscularly for 10 days); Gentamicin+ 2-APB group (injected 2 mg/kg 2-APB intraperitoneally, then after 30 minutes 100 mg/kg gentamicin was injected intramuscularly for 10 days). Blood samples were collected for biochemical analyses, kidney tissue samples were collected for light, electron microscopic and immunohistochemical investigations. In gentamicin group glomerular degeneration, tubular dilatation, vacuolization, desquamation of tubular cells and hyaline cast formation in luminal space and leukocyte infiltration were seen. Disorganization of microvilli of tubular cells, apical cytoplasmic blebbing, lipid accumulation, myelin figure like structure formation, increased lysosomes, mitochondrial swelling and disorganization of cristae structures, apoptotic changes and widening of intercellular space were found. TNF-α, IL-6 and caspase 3 expressions were increased. BUN and creatinine concentrations were increased. Increase in MDA levels and decrease in SOD activities were determined. Even though degeneration still continues in gentamicin+2-APB treatment group, severity and the area it occupied were decreased and the glomerular and tubule structures were generally preserved. TNF-α, IL-6, caspase 3 immunoreactivities and BUN, creatinine, MDA concentrations were reduced and SOD activities were increased markedly compared to gentamicin group. In conclusion, it has been considered that 2-APB can prevent gentamicin mediated nephrotoxicity with its anti-oxidant, anti-apoptotic and anti-inflammatory effects.


Assuntos
Nefropatias , Rim , Ratos , Animais , Caspase 3/metabolismo , Caspase 3/farmacologia , Aminoglicosídeos/efeitos adversos , Aminoglicosídeos/metabolismo , Ratos Wistar , Creatinina/metabolismo , Creatinina/farmacologia , Fator de Necrose Tumoral alfa , Interleucina-6 , Nefropatias/induzido quimicamente , Nefropatias/prevenção & controle , Antibacterianos/efeitos adversos , Antioxidantes/farmacologia , Gentamicinas/toxicidade , Gentamicinas/metabolismo , Superóxido Dismutase/metabolismo , Estresse Oxidativo
2.
Reprod Biol ; 18(1): 53-59, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29325695

RESUMO

In this study, we aimed to investigate the structural changes seen in the endometrium in experimental PCOS rat model and the effects of vitamin D treatment on these changes at immunohistochemical and electron microscopic levels. 24 prepubertal female rats were divided into three groups. Two groups were injected with dehydroepiandrosterone and one of them was treated with 1,25(OH)2 D3 at the same time. The control group was injected with sesame oil. At the end of the 28th day, the blood samples were collected. Uterus tissues were prepared for light and electron microscopic examinations. Epithelial, stromal and endometrial thickness measurements were investigated. Immunohistochemical staining was applied against caspase-3 and Ki-67. Serum AMH and estradiol levels were higher in PCOS group compared to the control group. Serum progesterone levels were similar in all groups. Endometrial, epithelial and stromal thickness measurements were increased in PCOS group compared to the control group, and decreased in the vitamin D treatment group compared to the PCOS group. Light and electron microscopic results of PCOS group showed an increase in apoptosis and proliferation. In the PCOS group, immunohistochemical staining of caspase-3 and Ki-67 were found to be higher than in the control group, but stainings were decreased with vitamin D treatment compared to PCOS group. Structural changes observed in endometrium may be related to implantation problems seen in patients with PCOS. Our studies suggest that vitamin D therapy may be beneficial in these patients.


Assuntos
Calcitriol/uso terapêutico , Modelos Animais de Doenças , Endométrio/efeitos dos fármacos , Síndrome do Ovário Policístico/tratamento farmacológico , Células Estromais/efeitos dos fármacos , Útero/efeitos dos fármacos , Deficiência de Vitamina D/tratamento farmacológico , Animais , Hormônio Antimülleriano/sangue , Apoptose/efeitos dos fármacos , Biomarcadores/sangue , Biomarcadores/metabolismo , Calcitriol/administração & dosagem , Caspase 3/metabolismo , Proliferação de Células/efeitos dos fármacos , Endométrio/metabolismo , Endométrio/patologia , Endométrio/ultraestrutura , Estradiol/sangue , Feminino , Imuno-Histoquímica , Injeções Subcutâneas , Antígeno Ki-67/metabolismo , Microscopia Eletrônica de Transmissão , Tamanho do Órgão/efeitos dos fármacos , Síndrome do Ovário Policístico/complicações , Síndrome do Ovário Policístico/metabolismo , Síndrome do Ovário Policístico/patologia , Progesterona/sangue , Ratos , Células Estromais/metabolismo , Células Estromais/patologia , Células Estromais/ultraestrutura , Útero/metabolismo , Útero/patologia , Útero/ultraestrutura , Deficiência de Vitamina D/complicações , Deficiência de Vitamina D/metabolismo , Deficiência de Vitamina D/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...